Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism

Altinova, ALEV; Toeruener, FÜSUN; Aktuerk, MÜJDE; Bukan, NESLİHAN; Cakir, Nuri; Ayvaz, Goeksun; Arslan, Metin

doi:10.1111/j.1365-2265.2006.02628.x

Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism

Atıf İçin Kopyala

Altinova A., Toeruener F. S., Aktuerk M. Y., Bukan N., Cakir N., Ayvaz G., ...Daha Fazla

CLINICAL ENDOCRINOLOGY, cilt.65, sa.4, ss.530-535, 2006 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 65 Sayı: 4
Basım Tarihi: 2006
Doi Numarası: 10.1111/j.1365-2265.2006.02628.x
Dergi Adı: CLINICAL ENDOCRINOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.530-535
Gazi Üniversitesi Adresli: Evet

Özet

Objective Adiponectin, an adipose tissue-derived hormone, has been reported to have anti-inflammatory and anti-atherogenic effects. The physiological effect of adiponectin on the metabolic changes and its relation with cardiovascular risk factors in thyroid dysfunction states is still not clear. The aim of the study was to evaluate plasma adiponectin level and its relation to cardiovascular risk factors in patients with thyroid dysfunction.